Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Palliative treatment of breast carcinoma Age: Adult |
Dose: Oral – 40 mg Frequency: 4 times daily |
|
Indication: Palliative treatment of breast carcinoma Age: Adult |
Dose: Oral – 160 mg Frequency: once daily |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Renal impairment – Use with caution Note: In normal renal function, 57-78% is excreted in urine within 10 days |
Administration
- Should be taken with food
- Take at same time daily
Side Effect
- Hypertension
- Insomnia
- mood swings Rash
- sweating
- Amenorrhea
- breakthrough bleeding
- change in menstrual flow
- hot sweats
- impotence
- spotting Diarrhea
- flatulence
- indigestion
- nausea
- vomiting
- weight gain
- Deep vein thrombosis (DVT) (DVT)
- Pulmonary embolism
- Thrombophlebitis
- Anemia
- Adrenal insufficiency
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Indinavir
|
Concentrations may be reduced
|
|
Cisplatin
|
Possible reduced efficacy
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe hepatic impairment
|
Risk of drug toxicity
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at 20° to 25°C. Protect from heat. Shake well immediately before use.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.